Minerva Neurosciences grants director 50,000 options
Minerva Neurosciences director Fouzia Laghrissi-Thode received a stock option grant covering 50,000 shares of common stock.
Rhea-AI Filing Summary
Minerva Neurosciences director Fouzia Laghrissi-Thode received a stock option grant covering 50,000 shares of common stock. The option has an exercise price of $4.68 per share and expires on June 2, 2036. It vests in four equal quarterly installments, with the first 12,500 shares vesting three months after June 3, 2026 and additional 12,500-share tranches vesting every three months thereafter, subject to her continued service as a non-employee director. This filing reports a compensation-related award rather than any open-market buying or selling of shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 50,000 shares
Grant/Award
1 txn
Insider
Laghrissi-Thode Fouzia
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 50,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 50,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.
Key Figures
Option grant size: 50,000 options
Exercise price: $4.68 per share
Expiration date: June 2, 2036
+3 more
6 metrics
Option grant size
50,000 options
Stock Option (right to buy) granted to director
Exercise price
$4.68 per share
Conversion or exercise price of stock option
Expiration date
June 2, 2036
Option expiry for director grant
Underlying shares
50,000 shares
Common Stock underlying granted option
Post-grant derivative holdings
50,000 options
Total derivative securities following transaction
Vesting installments
4 quarterly tranches
Equal installments every three months after June 3, 2026
Key Terms
Stock Option (right to buy), exercise price, vest, expiration date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 4.6800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"The shares subject to this option vest in four equal quarterly installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"expiration_date: 2036-06-02T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
non-employee director financial
"subject to the continued service of the Reporting Person as a non-employee director"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Fouzia Laghrissi-Thode receive in this Minerva Neurosciences (NERV) Form 4?
She received a stock option grant for 50,000 shares of common stock. The options are a compensation-related award, not an open-market purchase, and give her the right to buy shares at a fixed price if they vest.
What is the exercise price of the new Minerva Neurosciences (NERV) stock options?
The stock options have an exercise price of $4.68 per share. This means she can buy Minerva Neurosciences common stock at $4.68 for each option that vests and is exercised before expiration.
How do the 50,000 Minerva Neurosciences (NERV) options vest for Fouzia Laghrissi-Thode?
The 50,000 options vest in four equal quarterly installments of 12,500 shares each. Vesting starts three months after June 3, 2026, with additional tranches vesting every three months, contingent on her continued service as a non-employee director.
When do Fouzia Laghrissi-Thode’s Minerva Neurosciences (NERV) options expire?
The stock options expire on June 2, 2036. She must exercise vested options on or before that expiration date; any unexercised options after that date will no longer be exercisable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
